Research: LAMMERT and MATERN,

Listed in Issue 110

Abstract

LAMMERT and MATERN, Medizinische Klinik III, Universitatsklinikum Aachen, RWTH Aachen, Aachen, Germany, have reviewed (no references) the evidence base for the prevention of gallstones.

Background

Abstract: Cholesterol cholelithiasis (gallstones) is one of the most common and expensive gastrointestinal diseases. Beside common risk factors, recent molecular genetic studies have identified genetic risk factors for both cholesterol and pigment stone formation. Examples are low phospholipid-associated cholelithiasis due to mutations of the gene encoding an enzyme called the hepatocanalicular phosphatidylcholine transporter, and pigment stones in association with mutations of the ileal bile salt transporter gene. Evidence-based options for primary prevention of cholecystolithiasis include physical activity, slow weight reduction, regular vitamin C supplementation, and moderate coffee consumption. The ongoing genome projects are expected to provide the basis for future epidemiological studies of human gallstone (LITH) genes, which might offer new prospects for individual risk assessment and prevention of gallstones.

Methodology

Results

Conclusion

References

Lammert F, Matern S. Evidence-based prevention of cholecystolithiasis. Deutsche Medizinische Wochenschrift 129 (28-29): 1548-1550, Jul 9, 2004.

Comment

Next time that you hear of a scurrilous scare that vitamin C might cause gallstones, please remember that one of the gallstone prevention options cited in this research was vitamin C supplementation.

Munro Hall Clinic 2019

IJCA 2018 New Skyscraper

Scientific and Medical Network 2

Cycle India 2020

Walk on the Wide Side Trek Kenya 2020

Big Heart Bike Ride South Africa 2020

Scientific and Medical Network 2021

top of the page